Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Dako Denmark A/S
Dako Denmark A/S
Activities:
Manufacturing
Analysis
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Dako expands companion diagnostics collaboration with Amgen
Will pool their knowledge of drug diagnostic R&D and companion diagnostics
You need to be a subscriber to read this article.
Click here
to find out more.
Regulatory
Reimbursment issues hinder future development of personal therapies
The development of more targeted therapies is moving apace, but are the payers prepared for it? Dr Sarah Houlton looks at the progress of personalised medicines
Finance
Agilent to buy Dako for US$2.2bn
All-cash deal is largest in Agilent’s history
Analysis
FDA approves Dako diagnostic kit
Aid for breast cancer patients for whom Herceptin is being considered
Research & Development
Dako enters collaboration with Bristol-Myers Squibb
On the development of pharmacodiagnostic tests
Subscribe now